Filing Flows › Tonix Pharmaceuticals Holding (TNXP) › How it makes money
How Tonix Pharmaceuticals Holding (TNXP) makes money
Tonix Pharmaceuticals Holding (TNXP) made $13.5M of revenue in the second quarter 2026 (Q2 2026), +578% from a year earlier. Tonmya brought in $11.0M (81%); Zembrace Symtouch brought in $2.0M (15%); Tosymra brought in $594K (4%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Tonmya | $11.0M | 80.9% | +194% | — |
| Zembrace Symtouch | $2.0M | 14.7% | -32% | +27% |
| Tosymra | $594K | 4.4% | +174% | +39% |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $13.5M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $13.5M | +578% |
| Q1 2026 | $6.9M | +183% |
| Q4 2025 | $5.4M | +109% |
| Q3 2025 | $3.3M | +17% |
| Q2 2025 | $2.0M | -10% |
| Q1 2025 | $2.4M | -2% |
| Q4 2024 | $2.6M | -32% |
From Tonix Pharmaceuticals Holding's 10-Q filed Aug 10, 2026 (on EDGAR).
Questions
How does Tonix Pharmaceuticals Holding make money?
Tonix Pharmaceuticals Holding (TNXP) made $13.5M of revenue in the second quarter 2026 (Q2 2026), +578% from a year earlier. Tonmya brought in $11.0M (81%); Zembrace Symtouch brought in $2.0M (15%); Tosymra brought in $594K (4%).
What is Tonix Pharmaceuticals Holding's biggest business?
Tonmya: $11.0M in the second quarter 2026, 81% of revenue.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.